On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…
On Feb. 19, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported severe outcomes from COVID-19…
On Feb. 10, 2026, an Annenberg survey finds that a sizable majority of Americans think the three vaccines…
On Jan. 26, 2026, the American Academy of Pediatrics (AAP) released its 2026 immunization schedule and continues to…
On Jan. 23, 2026, a case-control study published in The Journal of Pediatrics reports that routine childhood vaccinations,…
On Nov. 12, 2025, UK researchers reported a test-negative, case-control study across 14 hospitals in England finds that the…
On Aug. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) Director Susan Monarez has left…
On Aug. 7, 2025, The first paper from a multi-year clinical research study has been published in The…
On Jul. 14, 2025, researchers at MIT and other institutions announced they had identified compounds that can fight…
On Jun. 26, 2025, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Jun. 12, 2025, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345),…
On Jun. 9, 2025, Merck announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA™ (clesrovimab-cfor) for…
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
On Apr. 16, 2025, A federal panel of medical experts has recommended an expansion of RSV vaccinations for…
On Jan. 24, 2025, researchers from the Veterans Affairs Portland Health Care System in Oregon reported results from…
On Jan. 3, 2025, the Centers for Disease Control and Prevention (CDC) reported that during Christmas week, respiratory…
On Dec. 23, 2024, an Annenberg Public Policy Center (APPC) health survey conducted in November 2024 showed that…
On Dec. 16, 2024, JAMA Network Open published a study demonstrating respiratory syncytial virus (RSV) vaccine effectiveness in adults…
On Dec. 16, 2024, a study published in BMC Cardiovascular Disorders shows that pediatric and young adult COVID-19…
On Nov. 21, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that by the week…
On Nov. 13, 2024, a study published in JAMA Network Open showed that respiratory syncytial virus (RSV) was…
On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
On Oct. 22, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO® (Respiratory…
On Oct. 24, 2024, GSK announced an $800 million investment that will bring state-of-the-art drug substance manufacturing and…
On Sept. 19, 2024, a U.S. population-based birth cohort study was released that showed that 53.4% of babies…
On Sep. 4, 2024, researcher led by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University…
On Aug. 28, 2024, survey data from the Annenberg Public Policy Center (APPC) found that the number of…
On Jul. 8, 2024, a study reported that babies exposed to maternal RSV (respiratory syncytial virus) vaccination in…
On Jun. 26, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendation for the…